Your browser doesn't support javascript.
loading
Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts.
Visconte, Valeria; Tabarroki, Ali; Zhang, Li; Parker, Yvonne; Hasrouni, Edy; Mahfouz, Reda; Isono, Kyoichi; Koseki, Haruhiko; Sekeres, Mikkael A; Saunthararajah, Yogen; Barnard, John; Lindner, Daniel; Rogers, Heesun J; Tiu, Ramon V.
Afiliação
  • Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue R40, Cleveland, OH, USA, 44195. visconv@ccf.org.
  • Tabarroki A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue R40, Cleveland, OH, USA, 44195. ali.tabarroki@gmail.com.
  • Zhang L; Department of Medicine, University of California, School of Medicine, San Francisco, CA, USA. Li.Zhang@ucsf.edu.
  • Parker Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue R40, Cleveland, OH, USA, 44195. parkery2@ccf.org.
  • Hasrouni E; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue R40, Cleveland, OH, USA, 44195. hasrouni86@gmail.com.
  • Mahfouz R; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue R40, Cleveland, OH, USA, 44195. mahfour@ccf.org.
  • Isono K; Center for Integrative Medical Sciences (IMS), RIKEN, Yokohama Institute, Yokohama, Japan. isono@rcai.riken.jp.
  • Koseki H; Center for Integrative Medical Sciences (IMS), RIKEN, Yokohama Institute, Yokohama, Japan. koseki@rcai.riken.jp.
  • Sekeres MA; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue R40, Cleveland, OH, USA, 44195. sekerem@ccf.org.
  • Saunthararajah Y; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. sekerem@ccf.org.
  • Barnard J; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue R40, Cleveland, OH, USA, 44195. saunthy@ccf.org.
  • Lindner D; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. saunthy@ccf.org.
  • Rogers HJ; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. barnarj@ccf.org.
  • Tiu RV; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue R40, Cleveland, OH, USA, 44195. lindned@ccf.org.
J Hematol Oncol ; 7: 89, 2014 Dec 07.
Article em En | MEDLINE | ID: mdl-25481243
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Ribonucleoproteína Nuclear Pequena U2 / Anemia Sideroblástica Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Ribonucleoproteína Nuclear Pequena U2 / Anemia Sideroblástica Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article